Evidence map›Paper›PMID 35345850›Full record

ArticleFrontiers in cell and developmental biology2022

Prevention of Triglyceridemia by (Non-)Anticoagulant Heparin(oids) Does Not Preclude Transplant Vasculopathy and Glomerulosclerosis.

Pragyi Shrestha, Kirankumar Katta, Ditmer Talsma, Annamaria Naggi, Jan-Luuk Hillebrands, Bart van de Sluis, Jacob van den Born

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Pragyi ShresthaDepartment of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Kirankumar KattaCenter for Eye Research, Department of Ophthalmology, Oslo University Hospital Ullevål, Oslo, Norway.
Ditmer TalsmaDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Annamaria NaggiRonzoni Institute, Milano, Italy.
Jan-Luuk HillebrandsMedical Biology-Pathology Division, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Bart van de SluisDepartment Pediatrics, Section Molecular Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Jacob van den BornDepartment of Nephrology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
University of Groningen · NLUniversity Medical Center Groningen · NLIstituto di Ricerche Chimiche e Biochimiche G. Ronzoni · ITOslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chronic transplant dysfunctiondyslipidemiaheparinpcsk9syndecan-1

Identifiers

PMID35345850
PMCPMC8957085
OpenAlexW4220981232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.